Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study.
about
Translatability of helminth therapy in inflammatory bowel diseasesThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsInfluence of environmental factors in the development of inflammatory bowel diseasesEnvironmental triggers for inflammatory bowel diseaseVenous and arterial disease in inflammatory bowel disease.Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responsesHeligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis.Recent advances in understanding ulcerative colitis.Drug-induced inflammatory bowel disease and IBD-like conditions.IBD across the age spectrum: is it the same disease?Drug-induced gastrointestinal disorders.Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: pathophysiology and clinical associations.Epidemiology, risk factors and management of cardiovascular diseases in IBD.Epidemiology and risk factors for IBD.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
P2860
Q22252437-1B44DEC6-58CF-42C4-9B64-DAE8AECF5E02Q26745700-7764B136-3D45-4D7C-88C2-57B9B99A41B9Q26768257-940D84CB-3A6C-4C8F-9A0B-7083C7C6AC04Q26851877-B7BB5218-D614-4CF7-BADF-28F916E91AFFQ34714365-DBB21544-ED90-4441-B17E-D3961CB0BA35Q36157891-6216A993-CA01-4816-A485-B423CCA0F49CQ36179511-DC255631-8A71-4CEF-90A2-3503D07C95A9Q37215636-780313DA-EBE0-43A9-807B-E84F8A3CE72FQ37954101-D6966475-7484-40D5-9BB8-B0726D3E185DQ38008983-1FEA8D9A-2E5C-482A-A65A-6077B3E5C165Q38171927-B51E223E-9B6F-4550-A156-58BA737A4CB1Q38221321-B713D68B-8391-4914-96A6-D5E6276C7656Q38250401-8FC83327-B048-408A-AEFA-CEE5255A2374Q38275040-11645FF5-D639-4495-BEA5-806690561814Q38366954-177100EC-060C-4FD3-BFEB-C3A28AF82703Q55312563-E4222A9D-C8A0-48E8-9D18-8EF7B8ED784E
P2860
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@en
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@nl
type
label
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@en
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@nl
prefLabel
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@en
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@nl
P2093
P2860
P50
P1476
Aspirin in the aetiology of Cr ...... pean prospective cohort study.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04784.X
P407
P577
2011-07-26T00:00:00Z